The changing face of Crohn’s disease: a population-based study of the natural history of Crohn’s disease in Örebro, Sweden 1963–2005

Abstract Objective: Changes in medical therapy and surgery might have influenced the natural history of Crohn’s disease (CD). Our aim was to explore the short-term outcome of CD and to specifically assess trends in disease phenotype, medications and surgery in the first five years from diagnosis. Material and methods: A population-based cohort comprising 472 CD patients diagnosed within the primary catchment area of Örebro University Hospital 1963–2005 were identified retrospectively and described. Data on medication, surgery, progression in disease location and behavior, were extracted from the medical records. Patients were divided into three cohorts based on year of diagnosis. Results: The proportion of patients with complicated disease behavior five years after diagnosis decreased from 54.4% (95%CI, 43.9–65.6) to 33.3% (27.4–40.0) in patients diagnosed 1963–1975 and 1991–2005, respectively (p = 0.002), whereas the proportion of patients progressing to complicated disease behavior was stable among those with non-stricturing, non-penetrating disease at diagnosis (p = 0.435). The proportion of patients undergoing surgery decreased from 65.8% (55.4–76.0) to 34.6% (28.6–41.5) in patients diagnosed 1963–1975 and 1991–2005, respectively (p < 0.001). The reduction in surgery preceded an increased use of immunomodulators and was explained by a decrease in surgery within three months from diagnosis (p = 0.001). Conclusions: We observed a striking decrease in complicated disease behavior and surgery five years after CD diagnosis, the latter largely due to a decrease in early surgery. Our findings suggest that the introduction of new treatments alone does not explain the reduction in surgery rates, the increasing proportion of patients with inflammatory disease at diagnosis also play an important role.

[1]  S. Hanauer,et al.  Treat to target: a proposed new paradigm for the management of Crohn's disease. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[2]  J. Halfvarson,et al.  Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn's disease in Örebro, Sweden: a population-based retrospective study. , 2014, Journal of Crohn's & colitis.

[3]  F. Dias de Castro,et al.  Tailoring Crohn's disease treatment: the impact of small bowel capsule endoscopy. , 2014, Journal of Crohn's & colitis.

[4]  M. Vatn,et al.  Early anti-TNF treatment in pediatric Crohn’s disease. Predictors of clinical outcome in a population-based cohort of newly diagnosed patients , 2014, Scandinavian journal of gastroenterology.

[5]  J. Andrews,et al.  Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohn's Disease , 2014, Inflammatory bowel diseases.

[6]  P. Munkholm,et al.  Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy , 2014, The American Journal of Gastroenterology.

[7]  A. Majeed,et al.  The Impact of Timing and Duration of Thiopurine Treatment on First Intestinal Resection in Crohn's Disease: National UK Population-Based Study 1989–2010 , 2014, The American Journal of Gastroenterology.

[8]  T. Cars,et al.  P622 Health care consumption and treatment of Crohn's disease in Stockholm County , 2014 .

[9]  S. Saxena,et al.  The Role of Thiopurines in Reducing the Need for Surgical Resection in Crohn's Disease: A Systematic Review and Meta-Analysis , 2014, The American Journal of Gastroenterology.

[10]  Subrata Ghosh,et al.  Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. , 2013, Gastroenterology.

[11]  G. Rogler,et al.  Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate , 2013, The American Journal of Gastroenterology.

[12]  M. Sans,et al.  Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. , 2013, Gastroenterology.

[13]  J. Mary,et al.  Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial. , 2013, Gastroenterology.

[14]  J. Wohlfahrt,et al.  Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979–2011 , 2013, Gut.

[15]  E. Louis Strategic Use of Immunosuppressants and Anti-TNF in Inflammatory Bowel Disease , 2013, Digestive Diseases.

[16]  H. Sokol,et al.  555 What Is the Prognosis of Silent Crohn's Disease ? , 2013 .

[17]  L. Dauchet,et al.  Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study , 2013, Gut.

[18]  G. Veres,et al.  Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009 , 2012, The American Journal of Gastroenterology.

[19]  S. Ng,et al.  Hospitalisations and surgery in Crohn's disease , 2012, Gut.

[20]  C. Bernstein,et al.  Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care. , 2011, Gastroenterology.

[21]  L. Biancone,et al.  Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. , 2011, Journal of Crohn's & colitis.

[22]  L. Peyrin-Biroulet,et al.  Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease , 2011, Gut.

[23]  A. Zinsmeister,et al.  Risk factors associated with progression to intestinal complications of Crohn's disease in a population-based cohort. , 2010, Gastroenterology.

[24]  Geraint T. Williams,et al.  Natural history of Crohn's disease in a population-based cohort from Cardiff (1986–2003): a study of changes in medical treatment and surgical resection rates , 2010, Gut.

[25]  P. Rutgeerts,et al.  Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. , 2008, Gastroenterology.

[26]  M. Vatn,et al.  Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[27]  P. Munkholm,et al.  Increasing Incidences of Inflammatory Bowel Disease and Decreasing Surgery Rates in Copenhagen City and County, 2003–2005: A Population-Based Study from the Danish Crohn Colitis Database , 2006, The American Journal of Gastroenterology.

[28]  M. Pochapin,et al.  Asymptomatic ileitis: past, present, and future. , 2006, Journal of clinical gastroenterology.

[29]  J. Satsangi,et al.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. , 2005, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[30]  L. Beaugerie,et al.  Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery , 2005, Gut.

[31]  M. Russel,et al.  Has disease outcome in Crohn's disease changed during the last four decades? , 2004, Alimentary pharmacology & therapeutics.

[32]  Samir A. Shah,et al.  Risk of early surgery for Crohn's disease: implications for early treatment strategies , 2003, American Journal of Gastroenterology.

[33]  R. McLeod Surgery for Inflammatory Bowel Diseases , 2003, Digestive Diseases.

[34]  V. Fazio,et al.  Evolution of surgery for Crohn's disease , 1999, Diseases of the colon and rectum.

[35]  G. D'Haens,et al.  Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. , 1999, Gastroenterology.

[36]  R. McLeod,et al.  Quality of Life of Patients with Inflammatory Bowel Disease after Surgery , 1998, World Journal of Surgery.

[37]  P. Munkholm,et al.  Intestinal cancer risk and mortality in patients with Crohn's disease. , 1993, Gastroenterology.

[38]  D. Sachar,et al.  Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. , 1988, Gut.

[39]  R. Farmer,et al.  Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. , 1985, Gastroenterology.

[40]  H. Mekhjian,et al.  Clinical features and natural history of Crohn's disease. , 1979, Gastroenterology.

[41]  G. Hellers Crohn's disease in Stockholm county 1955-1974. A study of epidemiology, results of surgical treatment and long-term prognosis. , 1979, Acta chirurgica Scandinavica. Supplementum.

[42]  R. Farmer,et al.  Indications for surgery in Crohn's disease: analysis of 500 cases. , 1976, Gastroenterology.

[43]  A. Peña,et al.  Course and prognosis of Crohn's disease. , 1976, Gut.